National Medical Care Co.’s H1 2017 net profit plunged by 62 percent year-on-year (YoY) to SAR 35 million, due to lower revenues following the implementation of new service prices upon instructions of the health ministry. Restructuring of the pharmaceuticals distribution unit also weighed on profit.
Item | 6m 2016 | 6m 2017 | Change |
---|---|---|---|
Revenues | 513.71 | 418.98 | (18.4 %) |
Gross Income | 151.59 | 91.44 | (39.7 %) |
Operating Income | 96.28 | 34.05 | (64.6 %) |
Net Income | 92.42 | 35.04 | (62.1 %) |
Average Shares | 44.85 | 44.85 | - |
EPS (Riyals) | 2.06 | 0.78 | (62.1 %) |
The company, which operates hospitals and medical centers across the Kingdom, posted a 67 percent decline YoY in Q2 net profit to SAR 19.5 million, hurt by restructuring of the pharmaceuticals distribution unit and lower revenue.
When compared to Q1 2017, net profit climbed 26 percent due to higher revenue and operating rates.
Item | Q2 2016 | Q2 2017 | Change |
---|---|---|---|
Revenues | 259.77 | 216.54 | (16.6 %) |
Gross Income | 84.30 | 50.25 | (40.4 %) |
Operating Income | 61.24 | 20.01 | (67.3 %) |
Net Income | 59.29 | 19.50 | (67.1 %) |
Average Shares | 44.85 | 44.85 | - |
EPS (Riyals) | 1.32 | 0.43 | (67.1 %) |
Item | Q1 2017 | Q2 2017 | Change |
---|---|---|---|
Revenues | 202.44 | 216.54 | 7.0 % |
Gross Income | 41.19 | 50.25 | 22.0 % |
Operating Income | 14.04 | 20.01 | 42.5 % |
Net Income | 15.54 | 19.50 | 25.5 % |
Average Shares | 44.85 | 44.85 | - |
EPS (Riyals) | 0.35 | 0.43 | 25.5 % |
Period | Revenues | Change | Gross Income | Change | Operating Income | Change |
---|---|---|---|---|---|---|
Q1 2008 | - | - | - | - | - | - |
Q2 2008 | - | - | - | - | - | - |
Q3 2008 | - | - | - | - | - | - |
Q4 2008 | - | - | - | - | - | - |
2008 | - | - | - | - | - | - |
Q1 2009 | 91.40 | - | 20.01 | - | 18.41 | - |
Q2 2009 | 95.71 | - | 19.86 | - | 18.66 | - |
Q3 2009 | 91.41 | - | 13.72 | - | 12.85 | - |
Q4 2009 | 95.93 | - | 22.60 | - | 5.26 | - |
2009 | 374.46 | - | 76.19 | - | 55.19 | - |
Q1 2010 | 110.53 | 20.9 % | 29.63 | 48.1 % | 25.92 | 40.8 % |
Q2 2010 | 110.45 | 15.4 % | 26.13 | 31.6 % | 20.87 | 11.8 % |
Q3 2010 | 95.98 | 5.0 % | 23.35 | 70.2 % | 18.86 | 46.8 % |
Q4 2010 | 109.27 | 13.9 % | 24.73 | 9.4 % | 16.44 | 212.5 % |
2010 | 426.22 | 13.8 % | 103.83 | 36.3 % | 82.09 | 48.7 % |
Q1 2011 | 114.09 | 3.2 % | 34.44 | 16.2 % | 28.80 | 11.1 % |
Q2 2011 | 119.28 | 8.0 % | 34.44 | 31.8 % | 27.76 | 33.0 % |
Q3 2011 | 106.50 | 11.0 % | 24.26 | 3.9 % | 18.42 | (2.3 %) |
Q4 2011 | 118.41 | 8.4 % | 28.19 | 14.0 % | 20.19 | 22.8 % |
2011 | 458.28 | 7.5 % | 121.33 | 16.9 % | 95.18 | 15.9 % |
Q1 2012 | 128.87 | 13.0 % | 35.53 | 3.2 % | 28.74 | (0.2 %) |
Q2 2012 | 137.27 | 15.1 % | 37.60 | 9.2 % | 30.40 | 9.5 % |
Q3 2012 | 121.00 | 13.6 % | 30.07 | 23.9 % | 21.63 | 17.4 % |
Q4 2012 | 137.61 | 16.2 % | 31.93 | 13.3 % | 23.24 | 15.1 % |
2012 | 524.75 | 14.5 % | 135.13 | 11.4 % | 104.01 | 9.3 % |
Q1 2013 | 145.36 | 12.8 % | 38.75 | 9.0 % | 31.05 | 8.0 % |
Q2 2013 | 142.20 | 3.6 % | 31.78 | (15.5 %) | 21.64 | (28.8 %) |
Q3 2013 | 134.56 | 11.2 % | 24.08 | (19.9 %) | 17.45 | (19.3 %) |
Q4 2013 | 164.16 | 19.3 % | 33.54 | 5.0 % | 21.42 | (7.8 %) |
2013 | 586.28 | 11.7 % | 130.06 | (3.8 %) | 91.55 | (12.0 %) |
Q1 2014 | 181.82 | 25.1 % | 42.99 | 10.9 % | 31.12 | 0.2 % |
Q2 2014 | 179.74 | 26.4 % | 56.27 | 77.0 % | 29.95 | 38.4 % |
Q3 2014 | 177.44 | 31.9 % | 40.16 | 66.8 % | 18.41 | 5.5 % |
Q4 2014 | 194.99 | 18.8 % | 37.85 | 12.9 % | 12.23 | (42.9 %) |
2014 | 733.99 | 25.2 % | 177.27 | 36.3 % | 92.67 | 1.2 % |
Q1 2015 | 219.43 | 20.7 % | 54.12 | 25.9 % | 29.12 | (6.4 %) |
Q2 2015 | 227.86 | 26.8 % | 64.96 | 15.4 % | 38.75 | 29.4 % |
Q3 2015 | 210.78 | 18.8 % | 50.78 | 26.5 % | 27.13 | 47.3 % |
Q4 2015 | 220.60 | 13.1 % | 50.34 | 33.0 % | 33.70 | 175.6 % |
2015 | 878.67 | 19.7 % | 220.20 | 24.2 % | 128.69 | 38.9 % |
Q1 2016 | 253.94 | 15.7 % | 67.29 | 24.3 % | 35.04 | 20.3 % |
Q2 2016 | 259.77 | 14.0 % | 84.30 | 29.8 % | 61.24 | 58.0 % |
Q3 2016 | 197.01 | (6.5 %) | 50.54 | (0.5 %) | 27.99 | 3.2 % |
Q4 2016 | 189.94 | (13.9 %) | 4.86 | (90.3 %) | (44.59) | (232.3 %) |
2016 | 900.65 | 2.5 % | 206.99 | (6.0 %) | 94.75 | (26.4 %) |
Q1 2017 | 202.44 | (20.3 %) | 41.19 | (38.8 %) | 14.04 | (59.9 %) |
Q2 2017 | 216.54 | (16.6 %) | 50.25 | (40.4 %) | 20.01 | (67.3 %) |
Period | Revenues | Change | Gross Income | Change | Operating Income | Change |
---|---|---|---|---|---|---|
2007 | - | - | - | - | - | - |
2008 | - | - | - | - | - | - |
2009 | 374.46 | - | 76.19 | - | 55.19 | - |
2010 | 426.22 | 13.8 % | 103.83 | 36.3 % | 82.09 | 48.7 % |
2011 | 458.28 | 7.5 % | 121.33 | 16.9 % | 95.18 | 15.9 % |
2012 | 524.75 | 14.5 % | 135.13 | 11.4 % | 104.01 | 9.3 % |
2013 | 586.28 | 11.7 % | 130.06 | (3.8 %) | 91.55 | (12.0 %) |
2014 | 733.99 | 25.2 % | 177.27 | 36.3 % | 92.67 | 1.2 % |
2015 | 878.67 | 19.7 % | 220.20 | 24.2 % | 128.69 | 38.9 % |
2016 | 900.65 | 2.5 % | 206.99 | (6.0 %) | 94.75 | (26.4 %) |
Period | Net Income | Change | EPS(Riyal) | Extraordinary Income/Expense | Net Profit Before Unusual Items | EPS Before XO Items |
---|---|---|---|---|---|---|
Q1 2008 | - | - | - | - | - | - |
Q2 2008 | - | - | - | - | - | - |
Q3 2008 | - | - | - | - | - | - |
Q4 2008 | - | - | - | - | - | - |
2008 | - | - | - | - | - | - |
Q1 2009 | 18.07 | - | 0.40 | - | 18.07 | 0.40 |
Q2 2009 | 17.04 | - | 0.38 | - | 17.04 | 0.38 |
Q3 2009 | 15.88 | - | 0.35 | - | 15.88 | 0.35 |
Q4 2009 | 5.72 | - | 0.13 | - | 5.72 | 0.13 |
2009 | 56.71 | - | 1.26 | - | 56.71 | 1.26 |
Q1 2010 | 25.67 | 42.1 % | 0.57 | - | 25.67 | 0.57 |
Q2 2010 | 20.70 | 21.5 % | 0.46 | - | 20.70 | 0.46 |
Q3 2010 | 20.51 | 29.2 % | 0.46 | - | 20.51 | 0.46 |
Q4 2010 | 17.87 | 212.4 % | 0.40 | - | 17.87 | 0.40 |
2010 | 84.75 | 49.4 % | 1.89 | - | 84.75 | 1.89 |
Q1 2011 | 28.58 | 11.3 % | 0.64 | - | 28.58 | 0.64 |
Q2 2011 | 28.64 | 38.4 % | 0.64 | - | 28.64 | 0.64 |
Q3 2011 | 18.54 | (9.6 %) | 0.41 | - | 18.54 | 0.41 |
Q4 2011 | 18.96 | 6.1 % | 0.42 | - | 18.96 | 0.42 |
2011 | 94.72 | 11.8 % | 2.11 | - | 94.72 | 2.11 |
Q1 2012 | 28.88 | 1.0 % | 0.64 | - | 28.88 | 0.64 |
Q2 2012 | 29.59 | 3.3 % | 0.66 | - | 29.59 | 0.66 |
Q3 2012 | 21.46 | 15.7 % | 0.48 | - | 21.46 | 0.48 |
Q4 2012 | 25.03 | 32.0 % | 0.56 | - | 25.03 | 0.56 |
2012 | 104.96 | 10.8 % | 2.34 | - | 104.96 | 2.34 |
Q1 2013 | 31.12 | 7.8 % | 0.69 | - | 31.12 | 0.69 |
Q2 2013 | 22.19 | (25.0 %) | 0.49 | - | 22.19 | 0.49 |
Q3 2013 | 18.80 | (12.4 %) | 0.42 | - | 18.80 | 0.42 |
Q4 2013 | 20.39 | (18.6 %) | 0.45 | - | 20.39 | 0.45 |
2013 | 92.50 | (11.9 %) | 2.06 | - | 92.50 | 2.06 |
Q1 2014 | 32.40 | 4.1 % | 0.72 | - | 32.40 | 0.72 |
Q2 2014 | 31.06 | 40.0 % | 0.69 | - | 31.06 | 0.69 |
Q3 2014 | 20.76 | 10.4 % | 0.46 | - | 20.76 | 0.46 |
Q4 2014 | 10.28 | (49.6 %) | 0.23 | - | 10.28 | 0.23 |
2014 | 95.46 | 3.2 % | 2.13 | - | 95.46 | 2.13 |
Q1 2015 | 27.72 | (14.4 %) | 0.62 | - | 27.72 | 0.62 |
Q2 2015 | 42.29 | 36.1 % | 0.94 | - | 42.29 | 0.94 |
Q3 2015 | 25.47 | 22.7 % | 0.57 | - | 25.47 | 0.57 |
Q4 2015 | 35.24 | 242.7 % | 0.79 | - | 35.24 | 0.79 |
2015 | 130.72 | 36.9 % | 2.91 | - | 130.72 | 2.91 |
Q1 2016 | 33.12 | 19.5 % | 0.74 | - | 33.12 | 0.74 |
Q2 2016 | 59.29 | 40.2 % | 1.32 | - | 59.29 | 1.32 |
Q3 2016 | 27.55 | 8.2 % | 0.61 | - | 27.55 | 0.61 |
Q4 2016 | (69.69) | (297.8 %) | (1.55) | (33.75) | (35.95) | (0.80) |
2016 | 50.27 | (61.5 %) | 1.12 | (33.75) | 84.02 | 1.87 |
Q1 2017 | 15.54 | (53.1 %) | 0.35 | - | 15.54 | 0.35 |
Q2 2017 | 19.50 | (67.1 %) | 0.43 | - | 19.50 | 0.43 |
Period | Net Income | Change | EPS(Riyal) | Extraordinary Income/Expense | Net Profit Before Unusual Items | EPS Before XO Items |
---|---|---|---|---|---|---|
2007 | - | - | - | - | - | - |
2008 | - | - | - | - | - | - |
2009 | 56.71 | - | 1.26 | - | 56.71 | 1.26 |
2010 | 84.75 | 49.4 % | 1.89 | - | 84.75 | 1.89 |
2011 | 94.72 | 11.8 % | 2.11 | - | 94.72 | 2.11 |
2012 | 104.96 | 10.8 % | 2.34 | - | 104.96 | 2.34 |
2013 | 92.50 | (11.9 %) | 2.06 | - | 92.50 | 2.06 |
2014 | 95.46 | 3.2 % | 2.13 | - | 95.46 | 2.13 |
2015 | 130.72 | 36.9 % | 2.91 | - | 130.72 | 2.91 |
2016 | 50.27 | (61.5 %) | 1.12 | (33.75) | 84.02 | 1.87 |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
Q1 2008 | - | - | - |
Q2 2008 | - | - | - |
Q3 2008 | - | - | - |
Q4 2008 | - | - | - |
2008 | - | - | - |
Q1 2009 | - | - | - |
Q2 2009 | - | - | - |
Q3 2009 | - | - | - |
Q4 2009 | 20.35 % | 20.91 % | 15.14 % |
2009 | 20.35 % | 20.91 % | 15.14 % |
Q1 2010 | 21.80 % | 22.04 % | 16.34 % |
Q2 2010 | 22.55 % | 22.04 % | 16.65 % |
Q3 2010 | 24.63 % | 23.32 % | 17.58 % |
Q4 2010 | 24.36 % | 25.12 % | 19.88 % |
2010 | 24.36 % | 25.12 % | 19.88 % |
Q1 2011 | 25.28 % | 25.61 % | 20.40 % |
Q2 2011 | 26.67 % | 26.85 % | 21.80 % |
Q3 2011 | 26.24 % | 26.11 % | 20.85 % |
Q4 2011 | 26.48 % | 26.55 % | 20.67 % |
2011 | 26.48 % | 26.56 % | 20.67 % |
Q1 2012 | 25.88 % | 25.84 % | 20.09 % |
Q2 2012 | 25.57 % | 25.38 % | 19.54 % |
Q3 2012 | 25.99 % | 25.46 % | 19.56 % |
Q4 2012 | 25.75 % | 25.14 % | 20.00 % |
2012 | 25.75 % | 25.14 % | 20.00 % |
Q1 2013 | 25.56 % | 24.89 % | 19.81 % |
Q2 2013 | 24.27 % | 23.17 % | 18.27 % |
Q3 2013 | 22.61 % | 21.99 % | 17.36 % |
Q4 2013 | 21.86 % | 20.98 % | 15.78 % |
2013 | 22.18 % | 20.98 % | 15.78 % |
Q1 2014 | 21.26 % | 20.31 % | 15.06 % |
Q2 2014 | 23.76 % | 21.17 % | 15.55 % |
Q3 2014 | 24.60 % | 20.97 % | 14.88 % |
Q4 2014 | 24.15 % | 19.46 % | 12.88 % |
2014 | 24.15 % | 19.59 % | 13.01 % |
Q1 2015 | 24.42 % | 18.66 % | 11.64 % |
Q2 2015 | 24.04 % | 18.90 % | 12.33 % |
Q3 2015 | 24.35 % | 19.23 % | 12.40 % |
Q4 2015 | 25.06 % | 21.32 % | 14.88 % |
2015 | 25.06 % | 21.32 % | 14.88 % |
Q1 2016 | 25.56 % | 21.44 % | 14.91 % |
Q2 2016 | 26.74 % | 23.27 % | 16.20 % |
Q3 2016 | 27.11 % | 23.91 % | 16.67 % |
Q4 2016 | 22.98 % | 16.07 % | 9.33 % |
2016 | 22.98 % | 17.75 % | 9.33 % |
Q1 2017 | 21.30 % | 14.58 % | 7.82 % |
Q2 2017 | 18.22 % | 10.27 % | 3.31 % |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
2007 | - | - | - |
2008 | - | - | - |
2009 | 20.35 % | 20.91 % | 15.14 % |
2010 | 24.36 % | 25.12 % | 19.88 % |
2011 | 26.48 % | 26.56 % | 20.67 % |
2012 | 25.75 % | 25.14 % | 20.00 % |
2013 | 22.18 % | 20.98 % | 15.78 % |
2014 | 24.15 % | 19.59 % | 13.01 % |
2015 | 25.06 % | 21.32 % | 14.88 % |
2016 | 22.98 % | 17.75 % | 9.33 % |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
Q1 2008 | - | - | - |
Q2 2008 | - | - | - |
Q3 2008 | - | - | - |
Q4 2008 | - | - | - |
Q1 2009 | 21.89 % | 25.72 % | 19.77 % |
Q2 2009 | 20.75 % | 24.92 % | 17.80 % |
Q3 2009 | 15.01 % | 20.39 % | 17.37 % |
Q4 2009 | 23.56 % | 12.80 % | 5.96 % |
Q1 2010 | 26.81 % | 28.92 % | 23.22 % |
Q2 2010 | 23.66 % | 24.55 % | 18.74 % |
Q3 2010 | 24.33 % | 25.97 % | 21.37 % |
Q4 2010 | 22.63 % | 21.09 % | 16.35 % |
Q1 2011 | 30.19 % | 30.66 % | 25.05 % |
Q2 2011 | 28.87 % | 29.19 % | 24.01 % |
Q3 2011 | 22.78 % | 22.91 % | 17.41 % |
Q4 2011 | 23.81 % | 23.21 % | 16.01 % |
Q1 2012 | 27.57 % | 27.57 % | 22.41 % |
Q2 2012 | 27.39 % | 27.12 % | 21.56 % |
Q3 2012 | 24.85 % | 23.55 % | 17.74 % |
Q4 2012 | 23.20 % | 22.29 % | 18.19 % |
Q1 2013 | 26.65 % | 26.37 % | 21.41 % |
Q2 2013 | 22.35 % | 20.42 % | 15.60 % |
Q3 2013 | 17.89 % | 18.61 % | 13.97 % |
Q4 2013 | 20.43 % | 18.63 % | 12.42 % |
Q1 2014 | 23.64 % | 22.99 % | 17.82 % |
Q2 2014 | 31.31 % | 23.55 % | 17.28 % |
Q3 2014 | 22.63 % | 18.45 % | 11.70 % |
Q4 2014 | 19.41 % | 13.33 % | 5.27 % |
Q1 2015 | 24.67 % | 19.55 % | 12.63 % |
Q2 2015 | 28.51 % | 23.38 % | 18.56 % |
Q3 2015 | 24.09 % | 19.85 % | 12.09 % |
Q4 2015 | 22.82 % | 22.37 % | 15.97 % |
Q1 2016 | 26.50 % | 20.19 % | 13.04 % |
Q2 2016 | 32.45 % | 29.83 % | 22.83 % |
Q3 2016 | 25.65 % | 22.64 % | 13.99 % |
Q4 2016 | 2.56 % | (15.05 %) | (18.93 %) |
Q1 2017 | 20.35 % | 15.00 % | 7.68 % |
Q2 2017 | 23.20 % | 16.81 % | 9.01 % |
Period | Shares Outstanding (M) | EPS (Riyal) | Adjusted EPS (Riyal) | Book Value (BV) |
---|---|---|---|---|
Q1 2008 | - | - | - | - |
Q2 2008 | - | - | - | - |
Q3 2008 | - | - | - | - |
Q4 2008 | - | - | - | - |
Q1 2009 | 44.85 | - | - | 8.46 |
Q2 2009 | 44.85 | - | - | 8.84 |
Q3 2009 | 44.85 | - | - | 9.19 |
Q4 2009 | 44.85 | 1.26 | 1.26 | 9.29 |
Q1 2010 | 44.85 | 1.43 | 1.43 | 9.87 |
Q2 2010 | 44.85 | 1.52 | 1.52 | 9.99 |
Q3 2010 | 44.85 | 1.62 | 1.62 | 10.45 |
Q4 2010 | 44.85 | 1.89 | 1.89 | 10.85 |
Q1 2011 | 44.85 | 1.95 | 1.95 | 10.85 |
Q2 2011 | 44.85 | 2.13 | 2.13 | 11.49 |
Q3 2011 | 44.85 | 2.09 | 2.09 | 11.90 |
Q4 2011 | 44.85 | 2.11 | 2.11 | 12.32 |
Q1 2012 | 44.85 | 2.12 | 2.12 | 12.97 |
Q2 2012 | 44.85 | 2.14 | 2.14 | 12.57 |
Q3 2012 | 44.85 | 2.20 | 2.20 | 13.04 |
Q4 2012 | 44.85 | 2.34 | 2.34 | 13.60 |
Q1 2013 | 44.85 | 2.39 | 2.39 | 18.19 |
Q2 2013 | 44.85 | 2.23 | 2.23 | 17.24 |
Q3 2013 | 44.85 | 2.17 | 2.17 | 17.65 |
Q4 2013 | 44.85 | 2.06 | 2.06 | 18.11 |
Q1 2014 | 44.85 | 2.09 | 2.09 | 17.28 |
Q2 2014 | 44.85 | 2.29 | 2.29 | 17.97 |
Q3 2014 | 44.85 | 2.33 | 2.33 | 18.46 |
Q4 2014 | 44.85 | 2.11 | 2.11 | 18.69 |
Q1 2015 | 44.85 | 2.00 | 2.00 | 19.26 |
Q2 2015 | 44.85 | 2.25 | 2.25 | 18.66 |
Q3 2015 | 44.85 | 2.36 | 2.36 | 19.22 |
Q4 2015 | 44.85 | 2.91 | 2.91 | 20.01 |
Q1 2016 | 44.85 | 3.03 | 3.03 | 20.60 |
Q2 2016 | 44.85 | 3.41 | 3.41 | 21.16 |
Q3 2016 | 44.85 | 3.46 | 3.46 | 21.75 |
Q4 2016 | 44.85 | 1.12 | 1.87 | 20.18 |
Q1 2017 | 44.85 | 0.73 | 1.48 | 20.51 |
Q2 2017 | 44.85 | (0.16) | 0.59 | 20.93 |
Period | Shares Outstanding (M) | EPS (Riyal) | Adjusted EPS (Riyal) | Book Value (BV) |
---|---|---|---|---|
2007 | - | - | - | - |
2008 | - | - | - | - |
2009 | 44.85 | 1.26 | 1.26 | 9.29 |
2010 | 44.85 | 1.89 | 1.89 | 10.85 |
2011 | 44.85 | 2.11 | 2.11 | 12.32 |
2012 | 44.85 | 2.34 | 2.34 | 13.60 |
2013 | 44.85 | 2.06 | 2.06 | 18.11 |
2014 | 44.85 | 2.13 | 2.13 | 18.69 |
2015 | 44.85 | 2.91 | 2.91 | 20.01 |
2016 | 44.85 | 1.12 | 1.87 | 20.18 |
Period | P/E | Adjusted P/E | Price/book |
---|---|---|---|
Q1 2008 | - | - | - |
Q2 2008 | - | - | - |
Q3 2008 | - | - | - |
Q4 2008 | - | - | - |
Q1 2009 | - | - | - |
Q2 2009 | - | - | - |
Q3 2009 | - | - | - |
Q4 2009 | - | - | - |
Q1 2010 | - | - | - |
Q2 2010 | - | - | - |
Q3 2010 | - | - | - |
Q4 2010 | - | - | - |
Q1 2011 | - | - | - |
Q2 2011 | - | - | - |
Q3 2011 | - | - | - |
Q4 2011 | - | - | - |
Q1 2012 | - | - | - |
Q2 2012 | - | - | - |
Q3 2012 | - | - | - |
Q4 2012 | - | - | - |
Q1 2013 | 30.02 | 30.02 | 3.94 |
Q2 2013 | 26.07 | 26.07 | 3.37 |
Q3 2013 | 25.16 | 25.16 | 3.09 |
Q4 2013 | 26.43 | 26.43 | 3.01 |
Q1 2014 | 29.41 | 29.41 | 3.56 |
Q2 2014 | 32.48 | 32.48 | 4.14 |
Q3 2014 | 32.55 | 32.55 | 4.11 |
Q4 2014 | 26.03 | 26.03 | 2.94 |
Q1 2015 | 30.88 | 30.88 | 3.21 |
Q2 2015 | 28.44 | 28.44 | 3.44 |
Q3 2015 | 22.37 | 22.37 | 2.74 |
Q4 2015 | 19.04 | 19.04 | 2.77 |
Q1 2016 | 16.69 | 16.69 | 2.46 |
Q2 2016 | 18.71 | 18.71 | 3.02 |
Q3 2016 | 15.98 | 15.98 | 2.54 |
Q4 2016 | 58.81 | 35.19 | 3.27 |
Q1 2017 | 73.26 | 36.05 | 2.60 |
Q2 2017 | NEG | 79.11 | 2.25 |
Period | P/E | Adjusted P/E | Price/book |
---|---|---|---|
2007 | - | - | - |
2008 | - | - | - |
2009 | - | - | - |
2010 | - | - | - |
2011 | - | - | - |
2012 | - | - | - |
2013 | 26.43 | 26.43 | 3.01 |
2014 | 25.77 | 25.77 | 2.94 |
2015 | 19.04 | 19.04 | 2.77 |
2016 | 58.81 | 35.19 | 3.27 |
Q2 2017
2017
Period | Medical Services | Pharmacies |
---|---|---|
Q1 2010 | 85.68 | 24.84 |
Q2 2010 | 84.16 | 26.29 |
Q3 2010 | 74.56 | 21.42 |
Q4 2010 | 84.07 | 25.20 |
Q1 2011 | 89.20 | 24.89 |
Q2 2011 | 94.51 | 24.77 |
Q3 2011 | 84.02 | 22.49 |
Q4 2011 | 93.61 | 24.79 |
Q1 2012 | 102.83 | 26.04 |
Q2 2012 | 109.44 | 27.83 |
Q3 2012 | 96.87 | 24.14 |
Q4 2012 | 109.84 | 27.76 |
Q1 2013 | 117.72 | 27.65 |
Q2 2013 | 115.21 | 26.98 |
Q3 2013 | 109.28 | 25.28 |
Q4 2013 | 134.04 | 30.12 |
Q1 2014 | 149.16 | 32.67 |
Q2 2014 | 149.31 | 30.43 |
Q3 2014 | 149.57 | 27.87 |
Q4 2014 | 161.93 | 33.06 |
Q1 2015 | 184.80 | 34.63 |
Q2 2015 | 196.41 | 31.45 |
Q3 2015 | 180.37 | 30.41 |
Q4 2015 | 191.80 | 28.80 |
Q1 2016 | 220.78 | 33.16 |
Q2 2016 | 230.14 | 29.62 |
Q3 2016 | 173.08 | 23.93 |
Q4 2016 | 162.66 | 27.28 |
Q1 2017 | 176.04 | 26.40 |
Q2 2017 | 190.13 | 26.41 |
Period | Medical Services | Pharmacies |
---|---|---|
2010 | 328.47 | 97.75 |
2011 | 361.34 | 96.95 |
2012 | 418.98 | 105.76 |
2013 | 476.25 | 110.02 |
2014 | 609.97 | 124.03 |
2015 | 753.38 | 125.28 |
2016 | 786.66 | 113.99 |
Item | Q2 2017 (e) | Q2 2017 (a) | Change |
---|---|---|---|
Average | 24.54 | 19.50 | (20.5 %) |
Item | Q2 2017 (e) | Q2 2017 (a) | Change |
---|---|---|---|
Al Rajhi Capital | 19.70 | 19.50 | (1.0) % |
Albilad Capital | 19.00 | 19.50 | 2.6 % |
Sico | 18.00 | 19.50 | 8.3 % |
Hermes | 22.00 | 19.50 | (11.4) % |
Arbah Capital | 22.80 | 19.50 | (14.5) % |
AlJazira Capital | 23.70 | 19.50 | (17.7) % |
HSBC | 29.00 | 19.50 | (32.8) % |
OSOOL AND BAKHEET | 42.10 | 19.50 | (53.7) % |
Current | |
Market Cap (M Riyal) | 8,844.42 |
Enterprise Value (EV) (M) | 8,734.69 |
Shares Outstanding ((M)) | 44.85 |
EPS ( Riyal) (TTM) | 6.41 |
Book Value (BV) ( Riyal) | 33.61 |
Par Value ( Riyal) | 10.00 |
Adjusted P/E (Last12) | 34.20 |
P/E (TTM) | 30.75 |
Price/book | 5.87 |
Return on Average Assets (%) (TTM) | 14.2 |
Return on Average Equity (%) (TTM) | 20.3 |
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}